Reference
- ROBERSON D: Crohn's trial shows the pros of antisense. Nature Med. (1997) 3:209.
- TU GC et al.: Tetranucleotide GGGA on mRNA is a potent target for antisense action. (1998). (Submitted).
- HODGSON J: Antisense companies reach reality. Nature Biotech. (1996) 14:815–816.